Cargando…

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’

Detalles Bibliográficos
Autores principales:	Takada, Kohichi, Sugita, Shintaro, Hasegawa, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779208/ https://www.ncbi.nlm.nih.gov/pubmed/33210422 http://dx.doi.org/10.1111/1759-7714.13751

Ejemplares similares

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report
por: Takada, Kohichi, et al.
Publicado: (2019)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma
por: Khanchel, Fatma, et al.
Publicado: (2021)

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

A Case Report of SMARCA4-Deficient Thoracic Sarcoma: A Rare and Aggressive Disease With a Grim Prognosis
por: Lalaoui Rachidi, Siham, et al.
Publicado: (2023)

Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study
por: Anžič, Nina, et al.
Publicado: (2021)

A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure
por: Ito, Shotaro, et al.
Publicado: (2021)

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
por: Rekhtman, Natasha, et al.
Publicado: (2019)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

SMARCA4-deficient uterine sarcoma: A case report and a concise review
por: Kord, Ali, et al.
Publicado: (2020)

Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report
por: Baa, Annie Kanchan, et al.
Publicado: (2021)

Thoracic SMARCA4-deficient undifferentiated tumor—a case of an aggressive neoplasm—case report
por: Roden, Anja C.
Publicado: (2021)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
por: Gao, Jie, et al.
Publicado: (2023)

SMARCA4-deficient thoracic tumor detected by [(18)F]FDG PET/CT
por: Okazaki, Tsubasa, et al.
Publicado: (2021)

Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
por: Shi, Liyong, et al.
Publicado: (2022)

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
por: Lin, Yun-Tzu, et al.
Publicado: (2023)

A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
por: Nakano, Yoshio, et al.
Publicado: (2022)

Thoracic SMARCA4‐deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report
por: Takemura, Chihiro, et al.
Publicado: (2023)

Pulmonary metastasectomy is associated with prolonged survival among patients with bone and soft tissue sarcoma
por: Shimizu, Junya, et al.
Publicado: (2020)

Response to: Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Cai, Juan, et al.
Publicado: (2019)

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022)

Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022)

Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
por: Maartens, Deborah Johanna, et al.
Publicado: (2023)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report
por: Sheng, Jin, et al.
Publicado: (2023)

Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report
por: Yang, Pan, et al.
Publicado: (2023)

Generation of new transgenic SMARCA4‐deficient mouse models results in neuromuscular weakness and paralysis of limbs
por: Neyazi, Sina, et al.
Publicado: (2022)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

‘Breakfast: how important is it really?’ A response
por: Littlecott, Hannah J, et al.
Publicado: (2016)

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
por: Hayasaka, Naotaka, et al.
Publicado: (2019)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT—Case Report
por: Sirák, Igor, et al.
Publicado: (2021)

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?
por: Hernández‐Pérez, José María, et al.
Publicado: (2022)

Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma
por: Sugita, Shintaro, et al.
Publicado: (2016)

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
por: Kunimasa, Kei, et al.
Publicado: (2021)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Is Silence Really Golden?
por: Gude, Dilip
Publicado: (2012)

Is CME Really Necessary?
por: Hall, G H
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ravi614v8r83kqpr012701k2qf